Suregraft 0.25 Tablet
Marketer
Hospimax Healthcare Pvt Ltd
Salt Composition
Everolimus (0.25mg)
Overview Suregraft 0.25 Tablet
Tacrolimus 0.25mg tablets help prevent organ rejection following transplantation by modulating the immune system's response to the new organ. This medication is also used alongside other treatments for breast, pancreatic, lung, and kidney cancers. Always adhere to your doctor's prescribed dosage and regimen. It can be taken with or without food, but consistency in timing is crucial. Overdosing can lead to severe adverse effects. Common side effects may include infections (respiratory or otherwise), fever, cough, tiredness, diarrhea, and fatigue. Report any persistent or troubling side effects to your physician immediately. Seek immediate medical attention for allergic reactions such as rash, breathing difficulties, swelling, or cough. Consult your doctor before taking this medicine if you experience excessive thirst, frequent urination, shortness of breath, cough, fever, or require any vaccinations. Always inform your doctor about all current medications and underlying health conditions before starting treatment. Pregnant or breastfeeding individuals must discuss this medication with their physician before use. Regular blood tests may be recommended to monitor the drug's effects. This medication may impact fertility in both men and women; discuss family planning with your doctor.
Primary Ingredients of Suregraft 0.25 Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Suregraft 0.25 Tablet
Preventing graft rejection in transplant recipients
Major Benefits of Suregraft 0.25 Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Suregraft 0.25mg tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Suregraft 0.25 Tablet:
- Infection
- Fever
- Cough
- Fatigue
- Diarrhea
- Upper respiratory tract infection
How to use Suregraft 0.25 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Suregraft 0.25mg tablets can be consumed with or without food, though consistent timing is recommended.
How Suregraft 0.25 Tablet works:
Suregraft 0.25 mg tablets modulate the body's immune response, thereby reducing the risk of organ transplant rejection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Suregraft 0.25 Tablet is of uncertain safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Suregraft 0.25 Tablet during pregnancy poses a confirmed risk to the fetus. Therefore, it's not recommended. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Suregraft 0.25 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Suregraft 0.25 Tablets may induce side effects that impair driving ability. Fatigue, a frequent side effect of Suregraft 0.25 Tablets, can also negatively impact driving capabilities.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Suregraft 0.25 Tablet without any required dosage modification.
LiverCAUTION
Patients with liver impairment should use Suregraft 0.25 Tablet cautiously, potentially requiring dosage modification under medical supervision. Suregraft 0.25 Tablet is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Suregraft 0.25 Tablet :
NA
Facts to Know About Suregraft 0.25 Tablet
| Label | Value |
|---|---|
| Chemical Type | Macrolide Antibiotics |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently
